Focus on getting more people on antiretroviral therapy as AIDS turns 30

Sunday marked the 30th anniversary of the first published report of the disease that came to be known as AIDS, the Los Angeles Times reports. Though the "promise" of a vaccine "has not materialized," "[s]ome progress has been made on other fronts," the newspaper writes (Healy/Maugh, 6/5).

"The development of antiretroviral drugs completely turned around the AIDS epidemic in the United States. The worst of the illness is now in Africa, where roughly two-thirds of the world's HIV cases are located," the San Francisco Chronicle states (Allday, 6/5). An estimated 6.6 million people in the developing world are on antiretroviral therapy, and there are 33.3 million people worldwide living with HIV infection, according to the Guardian. "The roll-out of drugs across the developing world, subsidised by the donors of richer countries, is saving millions of lives" (Boseley, 6/3).

"The challenge now is to put more infected people on antiretrovirals during tough economic times," VOA News reports. U.S. Global AIDS Coordinator Ambassador Eric Goosby, who began treating people with HIV during the beginning of the epidemic, said "[t]hese days, he sees a lot more people living with AIDS than dying from it," according to the news service (DeCapua, 6/3).

The White House Office of National AIDS Policy and Secretary of State Hillary Rodham Clinton released statements to mark the milestone.


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    IHME study reveals significant progress and gaps in the global fight against HIV/AIDS